Healthcare -
Biotechnology - NASDAQ - US
$ 2.385
-5.36 %
$ 313 M
Market Cap
-1.45
P/E
PRME - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities PRME - Prime Medicine, Inc.
18.7 M
LAST VALUE
50.14%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR